SAILOR FVF3689g

Research Title: A Study to Evaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

Sponsor: Genentech

Principal Investigator: Jay Stallman, M.D.

Description: This is a Phase IIIb, single-masked, 1-year multicenter study of the safety and tolerability of intravitreally administered ranibizumab in subjects with active subfoveal CNV secondary to AMD.

Start Date: November 2005

Recruitment: Completed

Project Personnel: Leslie Marcus, CCRC

Location(s): Decatur; 465 Winn Way, Suite 100, Decatur, GA 30030

Leslie Marcus

Clinical Research Coordinator

Leslie Marcus has more than seven years of clinical research experience. In addition to conducting ophthalmology studies, she has also coordinated clinical trials for conditions such as diabetes, chronic pain, hypercholesterolemia, insomnia, obesity, and osteoarthritis.

She received a Bachelor's of Science degree with a major in Nutrition and Food Science from Georgia Southern University in 2000 and became a Certified Clinical Research Coordinator through the Association of Clinical Research Professionals in 2004.